174 GSK Annual Report 2017 Notes to the financial statements continued 9.
Employee costs 2017 2016 2015 m m m Wages and salaries 7,116 6,391 6,132 Social security costs 802 733 633 Pension and other post-employment costs, including augmentations Note 28 616 541 467 Cost of share-based incentive plans 347 338 349 Severance and other costs from integration and restructuring activities 241 209 449 9,122 8,212 8,030 The increase in wages and salaries included the impact of movements in exchange rates.
The Group provides benefits to employees, commensurate with local practice in individual countries, including, in some markets, healthcare insurance, subsidised car schemes and personal life assurance.
The cost of share-based incentive plans is analysed as follows: 2017 2016 2015 m m m Share Value Plan 276 271 307 Performance Share Plan 47 39 26 Share option plans 4 4 4 Cash settled and other plans 20 24 12 347 338 349 The average monthly number of persons employed by the Group including Directors during the year was: 2017 2016 2015 Number Number Number Manufacturing 38,632 38,611 37,025 Selling, general and administration 49,141 49,961 52,121 Research and development 11,576 11,255 12,046 99,349 99,827 101,192 The average monthly number of Group employees excludes temporary and contract staff.
The numbers of Group employees at the end of each financial year are given in the financial record on page 250.
The monthly average number of persons employed by GlaxoSmithKline plc in 2017 was nil 2016 nil.
The compensation of the Directors and Senior Management members of the CET in aggregate, was as follows: 2017 2016 2015 m m m Wages and salaries 26 25 23 Social security costs 4 4 2 Pension and other post-employment costs 3 2 3 Cost of share-based incentive plans 22 15 18 55 46 46
